Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05127733
Other study ID # 031/2020
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 25, 2021
Est. completion date June 30, 2025

Study information

Verified date February 2024
Source Centre for Addiction and Mental Health
Contact Lena C. Quilty, PhD
Phone 4165358501
Email Lena.Quilty@camh.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and cost-effectiveness of Breaking Free Online, in a comparison of outpatients seeking treatment for substance use disorder who receive standard care with group peer support, versus with access to Breaking Free Online, versus with access to Breaking Free Online and individual peer support.


Description:

A total of 225 outpatients receiving standard care for substance use disorder from the Centre for Addiction and Mental Health will be randomized to receive clinical monitoring (CM) with group peer support, Breaking Free Online only, or Breaking Free Online with individual peer support, in an eight-week trial with a six-month follow-up period. The primary outcome is substance use frequency; secondary outcomes include substance use problems, depression, anxiety, quality of life, treatment engagement, and cost-effectiveness.


Recruitment information / eligibility

Status Recruiting
Enrollment 225
Est. completion date June 30, 2025
Est. primary completion date March 31, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. 18 years of age and above 2. Fluency in English 3. Understanding and willingness to comply with study requirements & provide informed consent 4. Current substance use disorder 5. Have used alcohol or substances within the past 30 days 6. Registration with CAMH Addictions Program outpatient services Exclusion Criteria: 1. Current psychosis or mania 2. Current psychiatric disorder requiring care more urgently than substance use, including acute intoxication or withdrawal requiring medical attention 3. Significant neurological disorder or physical illness likely to interfere with participants 4. Any known practical factors that would preclude participation (e.g., extended absences) 5. Inability to read at a sixth grade level

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Online Cognitive Behavioural Therapy
Interactive program utilizing cognitive behavioural therapy principles that guides users through its components and provides feedback, which facilitates behavior change (i.e., reduction in alcohol or substance use).
Individual Peer Support
Weekly meetings with a trained peer support worker who guides participants through the BFO platform, reviews the platform's content with them, and supports them in the creation of an action strategy based on the platform's suggestions.
Group Peer Support
Meetings with a group of peers led by a trained peer support worker/volunteer which will offer the participants an opportunity to discuss their experiences in a supportive and open environment.

Locations

Country Name City State
Canada Campbell Family Mental Health Research Institute Toronto Ontario

Sponsors (3)

Lead Sponsor Collaborator
Centre for Addiction and Mental Health Breaking Free Online (BFO), Community Addictions Peer Support Association (CAPSA)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Timeline Follow-Back Frequency (days) of substance use over the past 30 days 30 days
Secondary Qualitative Interview This interview will follow established principles of qualitative research and include questions specifically designed for this study. This interview will have a two-pronged focus including (1) barriers and facilitators to the implementation of online CBT and (2) a complementary ethnographic focus on "health work" patients engage in to understand the impact of online CBT and explore ways to optimally deliver support during the care journey. Thematic analysis of interview data will be undertaken to offer a summative description of how patients give meaning to their experience. 10 months
Secondary Program and Client Costs- Substance Abuse Treatment (PACC-SAT) Healthcare costs 7 days
Secondary Severity of Dependence Scale A self-report questionnaire assessing the severity of drug dependence. The minimum possible score is 0 and the maximum is 15, with higher scores indicating more severe dependence. 1 month
Secondary Alcohol Use Disorder Identification Test Alcohol use and associated harms. The minimum possible score is 0 and the maximum is 40, with higher scores indicating more harmful alcohol use. 1 month
Secondary Drug Use Disorders Identification Test Drug use and associated harms. The minimum possible score is 0 and the maximum is 44, with higher scores indicating more harmful drug use. 1 month
Secondary Patient Health Questionaire-9 Depression symptom severity. The minimum possible score is 0 and the maximum is 27, with higher scores indicating more severe depression. 14 Days
Secondary Generalized Anxiety Disorder-7 Generalized anxiety symptom severity. The minimum possible score is 0 and the maximum is 24, with higher scores indicating more severe anxiety. 14 days
Secondary World Health Organization Quality of Life Assessment Quality of life over four domains. Subscale scores are calculated for 4 domains (physical health, psychological, social relationships and environment) and for "overall" and "general health" quality of life. Subscale scores have a range of 0 to 100, with higher scores indicating greater quality of life. 4 weeks
Secondary Substance Use Calendar (SUC) This chart that will collect self-reports of alcohol and drug use and quantities of primary substance used. 14 days
Secondary Brief COPE Scale Frequency of use of different coping strategies in response to stressors. Each coping strategy is rated on a scale of 1 to 4, with higher scores indicating more use of the strategy. Baseline, up to 8 weeks, and up to 6 months
Secondary Adult Hope Scale Assessment of level of hope. The minimum possible score is 12 and the maximum is 96, with higher scores indicating higher levels of hope. Baseline, up to 8 weeks, and up to 6 months
Secondary Positive and Negative Affect Schedule - Expanded Form Positive and negative affect as well as additional specific affects. The minimum score for each emotion is 1 and the highest possible score for each emotion is 5, with higher scores indicating more intensity of that emotion. Composite scores are computed for general positive and general negative affect, with a minimum total score of 10 and a maximum total score of 50 for each type, with higher scores indicating higher presence of that type of affect. Additional specific affect total scores are also computed with higher scores indicating more presence of the affect. 30 days
Secondary Contemplation Ladder Assessment of participant perspectives about changing substance use. The minimum score is 1 and the highest possible score is 10, with higher scores indicating more change in substance use. Baseline, up to 8 weeks, and up to 6 months
Secondary Treatment Acceptability/Adherence Scale Treatment acceptability and anticipated or actual adherence in response to a given treatment. The minimum possible score is 10 and the maximum is 70, with higher scores indicating more acceptability or adherence to the treatment. Baseline, up to 8 weeks, and up to 6 months
Secondary World Health Organization Disability Assessment Schedule 2.0 Overall level of functioning. The minimum possible score is 0 and the maximum is 100, with higher scores indicating more disability. 30 days
See also
  Status Clinical Trial Phase
Recruiting NCT05660434 - Using Aromatherapy in Substance Use Disorder N/A
Recruiting NCT05338268 - Substance Use and Loneliness N/A
Completed NCT04098614 - Barriers to Substance Use Disorder Recovery N/A
Completed NCT03954184 - E-health Implementation (Iowa) N/A
Completed NCT03590106 - Cardiac Surgery Peer Recovery Support Program N/A
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Recruiting NCT06273228 - Parenting Young Children in Pediatrics N/A
Recruiting NCT05327504 - Written Exposure Therapy for Veterans With SUD and PTSD N/A
Terminated NCT03517111 - The Impact of a Parenting Intervention on Latino Youth Health Behaviors N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT04401215 - Technologically-Augmented Referrals to Mitigate Addiction Consequences N/A
Not yet recruiting NCT06187701 - Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Active, not recruiting NCT02382042 - Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans N/A
Completed NCT01237366 - Study Targeting Affect Regulation Phase 1/Phase 2
Terminated NCT01356667 - Drum-Assisted Therapy for Native Americans N/A
Completed NCT00708890 - Twelve Step Based Self-help Groups for Substance Related Disorders N/A
Active, not recruiting NCT04048850 - Zepatier in Patients With Substance Use
Recruiting NCT05976646 - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion Phase 1/Phase 2
Recruiting NCT06094972 - The Effectiveness of A-CRA in Compulsory Institutional Care for Youth N/A